Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tightly locked optical frequency comb from a semiconductor disk laser.

Optics express·2019
Same author

Programmable pulse shaping for time-gated amplifiers.

Optics express·2019
Same author

Sub-150-fs pulses from an optically pumped broadband modelocked integrated external-cavity surface emitting laser.

Optics letters·2019
Same author

High-power OPCPA generating 1.7 cycle pulses at 2.5 µm.

Optics express·2018
Same author

Orientation-dependent stereo Wigner time delay and electron localization in a small molecule.

Science (New York, N.Y.)·2018
Same author

Gas-lens effect in kW-class thin-disk lasers.

Optics express·2018

Related Experiment Video

Updated: Jul 17, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

From obesity to diabetes.

U Keller1

  • 1University Hospital Basel, CH-4031 Basel, Switzerland. ukeller@uhbs.ch

International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition
|January 24, 2007
PubMed
Summary

Obesity significantly increases the risk of insulin resistance and type 2 diabetes by affecting adipocyte function and increasing free fatty acids. Lifestyle changes, including weight loss and increased physical activity, are crucial for preventing diabetes development.

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Experiment Videos

Last Updated: Jul 17, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Area of Science:

  • Metabolic disorders and endocrinology
  • Obesity and diabetes research
  • Cardiovascular risk factors

Background:

  • Rising global obesity rates are linked to increased insulin resistance and type 2 diabetes.
  • Obesity, particularly visceral obesity, is a key component of the metabolic syndrome, characterized by insulin resistance, hypertension, and dyslipidemia.
  • Adipocytes contribute to insulin resistance through free fatty acid release and secretion of inflammatory cytokines like TNF-alpha and interleukin-6.

Purpose of the Study:

  • To review the pathogenetic mechanisms linking obesity and type 2 diabetes.
  • To highlight the role of adipocytes and associated molecular factors in insulin resistance.
  • To discuss the therapeutic potential of PPAR-gamma agonists and the importance of lifestyle interventions.

Main Methods:

  • Review of scientific literature on obesity, insulin resistance, and type 2 diabetes.
  • Analysis of the molecular and cellular mechanisms involved in metabolic dysfunction.
  • Examination of clinical trial data on lifestyle interventions and pharmacological treatments.

Main Results:

  • Excess adipocytes impair insulin sensitivity and contribute to the metabolic syndrome.
  • Adipocytes secrete factors (adiponectin, resistin, TNF-alpha, IL-6) that promote insulin resistance.
  • Increased free fatty acids negatively impact glucose metabolism and pancreatic beta-cells.
  • Visceral adipose tissue enhances cortisol metabolism, contributing to insulin resistance.
  • Thiazolidinediones (glitazones) improve insulin sensitivity by targeting PPAR-gamma.
  • Lifestyle modifications (weight loss, physical activity, diet) significantly inhibit progression from prediabetes to type 2 diabetes.

Conclusions:

  • Obesity is a primary driver of insulin resistance and type 2 diabetes through complex pathogenetic mechanisms.
  • Targeting adipocyte dysfunction and metabolic pathways offers therapeutic strategies.
  • Lifestyle interventions, including weight management and physical activity, are fundamental for diabetes prevention.